Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
BMC Endocrine Disorders
|
October 2, 2020
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
Guttorm Raknes, Lars Småbrekke
Pharmacoepidemiology and Drug Safety
|
September 28, 2016
A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
Guttorm Raknes, Lars Småbrekke
Plos One
|
October 2, 2019
Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
Guttorm Raknes, Lars Småbrekke
Scientific Reports
|
October 23, 2019
Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study
Guttorm Raknes, Lars Småbrekke
Plos One
|
November 4, 2017
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
Guttorm Raknes, Lars Småbrekke
Plos One
|
February 15, 2019
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
Guttorm Raknes, Lars Småbrekke
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
May 19, 2009
[Pharmacological treatment of acute cough]
Lars Småbrekke, Hasse Melbye
Pharmacoepidemiology and Drug Safety
|
April 4, 2017
Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database
Guttorm Raknes, Lars Småbrekke
Journal of Crohn'S & Colitis
|
February 1, 2018
The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
Guttorm Raknes, Pia Simonsen, Lars Småbrekke
Pharmacoepidemiology and Drug Safety
|
May 7, 2014
MAT-CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community-acquired pneumonia
June Utnes Høgli, Lars Småbrekke, Beate Hennie Garcia
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
BMC Endocrine Disorders
|
October 2, 2020
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
Guttorm Raknes, Lars Småbrekke
Pharmacoepidemiology and Drug Safety
|
September 28, 2016
A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
Guttorm Raknes, Lars Småbrekke
Plos One
|
October 2, 2019
Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
Guttorm Raknes, Lars Småbrekke
Scientific Reports
|
October 23, 2019
Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study
Guttorm Raknes, Lars Småbrekke
Plos One
|
November 4, 2017
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
Guttorm Raknes, Lars Småbrekke
Plos One
|
February 15, 2019
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
Guttorm Raknes, Lars Småbrekke
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
May 19, 2009
[Pharmacological treatment of acute cough]
Lars Småbrekke, Hasse Melbye
Pharmacoepidemiology and Drug Safety
|
April 4, 2017
Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database
Guttorm Raknes, Lars Småbrekke
Journal of Crohn'S & Colitis
|
February 1, 2018
The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
Guttorm Raknes, Pia Simonsen, Lars Småbrekke
Pharmacoepidemiology and Drug Safety
|
May 7, 2014
MAT-CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community-acquired pneumonia
June Utnes Høgli, Lars Småbrekke, Beate Hennie Garcia
Page
of 5